Editor's letter

Issue 76 • July 2024

Don’t miss out – sign up to our free industry-leading magazine and newsletters

Follow us on Twitter

Welcome to the latest issue of the Medical Technology magazine

In this month’s edition of Medical Technology, we look at the promising future of bioplastics in medical devices.

In an era where sustainability is paramount, the most promising technological innovations are now targeting reduced use of plastics in medical devices. While bioplastics remain a niche with only 1% of total plastic production, there is a movement towards their wider development. According to European Bioplastics, in 2020, global production capacity exceeded 2.1 million tonnes, and is projected to reach 2.9 million tonnes by 2025.

We also look at the strategies device manufacturers are adopting to overcome supply chain challenges. As of 2024, manufacturers are allocating 3-5% of their revenue on supply chain services and supply chain costs represent up to 20% of their revenue.

All this and the latest medical device industry news, comment, and analysis from GlobalData.  

Catherine Longworth, editor

Go to article: Home | The rise of bioplastics in medical devicesGo to article: Editor's letterGo to article: ContentsGo to article: On Line ControlsGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: Alleima Company InsightGo to article: AlleimaGo to article: In DepthGo to article: The rise of bioplastics in medical devices Go to article: Medtech’s digital supply chain revolution: innovations and challenges in 2024 Go to article: Vibrating gastric stimulators – the next big obesity treatment? Go to article: Explainer: Why have there been so many job cuts in MedTech?Go to article: Telehealth in the US: adapt or die? Go to article: Transforming surgery: Microbot Medical and Boston hospital collaborate on Liberty Surgical Robot trialsGo to article: Australia’s biggest week in Medtech in AdelaideGo to article: ASCO 2024 unveils practice-changing research in oncology, from new chemo regimens, to immunotherapy and beyondGo to article: Frankfurt Laser CompanyGo to article: Sponsored supplementsGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Next issue